News | Magnetic Resonance Imaging (MRI) | July 24, 2025

Following the recent FDA clearance of the new Swoop System, two leading hospitals in the U.S. have purchased the first commercial units, marking the launch of next-generation portable MR brain imaging.

Hyperfine Announces the First Commercial Sales of the Next-Gen Portable MRI  System

July 17, 2025 – Hyperfine, Inc.recently announced the first commercial sales of the next-generation Swoop system.The Swoop system is the first FDA-cleared AI-powered portable MRI system for the brain. The Swoop system is powered by proprietary Optive AI software.

Two pioneering hospitals in the northeast U.S. plan to utilize the technology in their intensive care units and emergency department settings.

The initial sales of the next-generation Swoop system—purchased by two top-tier hospitals in the northeastern United States—demonstrate a strong market response following FDA clearance and mark a critical step toward the widespread clinical adoption of portable brain imaging with diagnostic-level clarity.

“This marks the start of a new phase for Hyperfine — one where our vision to transform MRI access is driven by a new system that is commercially ready, is clinically valuable, has outstanding image quality and functionality, and is garnering strong customer interest,” commented Maria Sainz, president and CEO of Hyperfine. “Attaining the milestone of first commercial sales and deliveries of the new Swoop system just weeks after FDA clearance is the result of seamless execution across the organization — from industry-leading product development to accelerated clearance to rapid manufacturing ramp to initial sales. We are excited about the momentum with the new Swoop system and the growth we anticipate in the second half of 2025 and beyond.”

The new Swoop system features innovations specifically engineered to deliver the highest signal-to-noise ratio, which, when paired with the Optive AI software, achieve exceptional image quality, including improved resolution, uniformity, and faster acquisition times. This new level of image quality has the potential to dramatically drive the adoption of the Swoop system across sites of care and multiple clinical applications. The new Swoop® system also delivers a user and patient-centric design to accommodate a broad patient population—especially beneficial for pediatric, elderly, or anxious patients—making MRI more accessible for all.

For more information about the Swoop Portable MR Imaging system, please visit HyperfineMRI.com.


Related Content

News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Pediatric Imaging

July 17, 2026 — In June, UW Health Kids began welcoming patients into a new state-of-the-art imaging suite dedicated to ...

Time July 23, 2026
arrow
News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | Cardiac Imaging

July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...

Time July 15, 2026
arrow
News | Radiation Oncology

July 10, 2026 — A new study led by researchers at the Icahn School of Medicine at Mount Sinai found that although the ...

Time July 10, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Radiation Oncology

July 8, 2026 — GE HealthCare and Mayo Clinic have announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
Subscribe Now